TG Therapeutics Ownership | Who Owns TG Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

TG Therapeutics Ownership Summary

TG Therapeutics is owned by 63.80% institutional investors, 9.53% insiders, and 26.67% retail investors. Vanguard group is the largest institutional shareholder, holding 9.36% of TGTX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.46% of its assets in TG Therapeutics shares.

TGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TG Therapeutics	63.80%	9.53%	26.67%
Sector	Healthcare Stocks	47.38%	7.99%	44.63%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	13.69M	9.36%	$243.58M
Blackrock	11.39M	7.79%	$202.60M
State street	6.70M	4.58%	$119.12M
Soleus capital management	3.65M	2.49%	$64.85M
Pictet asset management sa	3.24M	2.22%	$57.70M
Geode capital management	3.21M	2.19%	$57.05M
Deep track capital, lp	2.87M	1.96%	$51.06M
Opaleye management	2.28M	1.56%	$40.56M
Goldman sachs group	2.08M	1.43%	$37.09M
Bank of america corp /de/	2.08M	1.42%	$37.04M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Opaleye management	2.28M	9.27%	$40.56M
Soleus capital management	3.65M	5.72%	$64.85M
Exome asset management	251.60K	3.98%	$4.48M
M28 capital management lp	161.60K	3.73%	$2.87M
Ghost tree capital	500.00K	2.79%	$8.89M
683 capital management	1.40M	1.88%	$24.91M
Sofinnova investments	1.86M	1.72%	$33.11M
Deep track capital, lp	2.87M	1.52%	$51.06M
Spotlight asset group	82.10K	1.02%	$1.46M
Quantum private wealth	103.60K	0.65%	$1.84M

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	2.87M	1.52%	2.87M
Two sigma investments, lp	1.36M	0.06%	1.10M
Goldman sachs group	2.08M	0.01%	798.28K
Norges bank	597.30K	0.00%	597.30K
Blackrock	11.39M	0.00%	544.84K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	65.07K	0.00%	-3.09M
Marshall wace, llp	-	-	-2.05M
State street	6.70M	0.01%	-1.10M
Vestal point capital, lp	-	-	-1.05M
Balyasny asset management	-	-	-802.00K

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	2.87M	1.52%	2.87M	$51.06M
Norges bank	597.30K	0.00%	597.30K	$10.63M
Assenagon asset management	488.94K	0.02%	488.94K	$8.70M
Two sigma advisers, lp	166.10K	0.01%	166.10K	$2.95M
State of new jersey common pension fund d	113.68K	0.01%	113.68K	$2.02M

Sold Out

Holder	Change
Quest partners	-1.00
Financial gravity asset management	-5.00
Ica group wealth management	-25.00
Federation des caisses desjardins du quebec	-40.00
Innealta capital	-41.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	273	4.20%	93,287,913	4.27%	63	1.63%	142	12.70%	67	-10.67%
Mar 31, 2024	262	1.16%	89,470,240	-0.55%	62	1.58%	126	9.57%	75	2.74%
Dec 31, 2023	259	0.39%	89,964,121	0.71%	62	1.58%	115	-16.67%	73	25.86%
Sep 30, 2023	258	-5.84%	89,331,949	1.53%	63	1.61%	138	-0.72%	58	-19.44%
Jun 30, 2023	274	19.65%	87,984,592	-6.87%	62	1.38%	139	18.80%	72	12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	8.50M	5.46%	7.72K
Vanguard Total Stock Mkt Idx Inv	4.36M	2.82%	3.80K
SPDR® S&P Biotech ETF	3.75M	2.43%	41.55K
iShares Russell 2000 ETF	3.59M	2.31%	-8.08K
Vanguard Small Cap Index	3.49M	2.25%	-35.12K
Vanguard Institutional Extnd Mkt Idx Tr	2.00M	1.29%	-62.14K
Vanguard Small Cap Growth Index Inv	1.92M	1.24%	-20.90K
Pictet-Biotech P USD	1.88M	1.22%	-10.36K
Pictet Biotech	1.79M	1.16%	1.79M
Fidelity Small Cap Index	1.43M	0.92%	-35.36K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 11, 2024	Lonial Sagar	-	Sell	$152.20K
Nov 11, 2024	Charney Laurence N	-	Sell	$754.88K
Nov 05, 2024	Echelard Yann	-	Sell	$489.60K
Jun 20, 2024	Lonial Sagar	-	Sell	$275.79K
Jun 17, 2024	Lonial Sagar	-	Sell	$157.10K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	3
2024 Q2	-	2
2024 Q1	-	4
2023 Q3	1	-
2023 Q2	-	2

TGTX Ownership FAQ

Who Owns TG Therapeutics?

TG Therapeutics shareholders are primarily institutional investors at 63.80%, followed by 9.53% insiders and 26.67% retail investors. The average institutional ownership in TG Therapeutics's industry, Biotech Stocks , is 45.43%, which TG Therapeutics exceeds.

Who owns the most shares of TG Therapeutics?

TG Therapeutics’s largest shareholders are Vanguard group (13.69M shares, 9.36%), Blackrock (11.39M shares, 7.79%), and State street (6.7M shares, 4.58%). Together, they hold 21.73% of TG Therapeutics’s total shares outstanding.

Does Blackrock own TG Therapeutics?

Yes, BlackRock owns 7.79% of TG Therapeutics, totaling 11.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 202.6M$. In the last quarter, BlackRock increased its holdings by 544.84K shares, a 5.02% change.

Who is TG Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is TG Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.27% of its assets in 2.28M TG Therapeutics shares, valued at 40.56M$.

Who is the top mutual fund holder of TG Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of TG Therapeutics shares, with 5.46% of its total shares outstanding invested in 8.5M TG Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools